The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus.

Kaposi's sarcoma-associated herpesvirus (KSHV) is a novel human herpesvirus closely linked to two AIDS-related neoplasms. We have prepared DNA from KSHV virions produced in cell culture and have examined the structure of the viral genomic termini. As in the related simian herpesvirus H. saimiri (HVS), the central unique region of KSHV DNA is bounded by tandemly repeated units of noncoding, GC-rich DNA. The KSHV repeats are 803 bp in length and are 85% G+C. Each molecule harbors 35-45 such repeats, but the repeats are not arrayed uniformly and symmetrically at each end. Rather, different molecules appear to contain different numbers of repeats at each end, with the sum total of repeated DNA per genome being relatively fixed, since the full genome is uniformly 165-170 kb. Thus, molecules with many repeats at one end will have fewer at the other. Because the unique viral genes bordering the left-hand repeats of the HVS genome play key roles in oncogenesis, we also examined the coding organization of the corresponding region of KSHV. No homologs of the HVS transforming genes were identified in this region of KSHV; rather, this region bears a novel gene encoding a putative transmembrane protein that appears to be upregulated during the early phase of lytic viral replication.

[1]  C. Boshoff,et al.  Kaposi's sarcoma-associated herpesvirus. , 1997, Advances in cancer research.

[2]  J. Russo,et al.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[3]  W. Zhong,et al.  The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions , 1996, Journal of virology.

[4]  E. Operskalski,et al.  The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma–associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission , 1996, Nature Medicine.

[5]  J. Phair,et al.  KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma , 1996, Nature Medicine.

[6]  S. Rafii,et al.  Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells , 1996, The Journal of experimental medicine.

[7]  M. McGrath,et al.  Lytic growth of Kaposi's sarcoma–associated herpesvirus (human herpesvirus 8) in culture , 1996, Nature Medicine.

[8]  E. Cesarman,et al.  Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae , 1996, Journal of virology.

[9]  P. Biberfeld,et al.  A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma , 1995, Nature Medicine.

[10]  E. Cesarman,et al.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. , 1995, The New England journal of medicine.

[11]  P. Moore,et al.  Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. , 1995, The New England journal of medicine.

[12]  J. Ambroziak,et al.  Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. , 1995, Science.

[13]  E. Cesarman,et al.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.

[14]  M. Kanehisa,et al.  A knowledge base for predicting protein localization sites in eukaryotic cells , 1992, Genomics.

[15]  Albrecht,et al.  Primary structure of the herpesvirus saimiri genome , 1992, Journal of virology.

[16]  R. Gallo,et al.  Pathogenesis of AIDS. , 1992, The Journal of pharmacy and pharmacology.

[17]  V. Beral,et al.  Cancer, HIV and AIDS. , 1991, Cancer surveys.

[18]  R. Desrosiers,et al.  Identification of transforming genes of subgroup A and C strains of Herpesvirus saimiri. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[19]  R. Gallo,et al.  Pathogenesis of AIDS-associated Kaposi's sarcoma. , 1991, Hematology/oncology clinics of North America.

[20]  V. Beral,et al.  Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? , 1990, The Lancet.

[21]  R. Desrosiers,et al.  Deletion mutants of herpesvirus saimiri define an open reading frame necessary for transformation , 1989, Journal of virology.

[22]  J. Steitz,et al.  Four novel U RNAs are encoded by a herpesvirus , 1988, Cell.

[23]  G. Heijne A new method for predicting signal sequence cleavage sites. , 1986 .

[24]  A. Bankier,et al.  Terminal repetitive sequences in herpesvirus saimiri virion DNA , 1985, Journal of virology.

[25]  B. Fleckenstein,et al.  Structure of Herpesvirus saimiri genomes: arrangement of heavy and light sequences in the M genome , 1976, Journal of virology.

[26]  R. Grant,et al.  Frequent presence of a novel herpesvirus genome in lesions of human immunodeficiency virus-negative Kaposi's sarcoma. , 1996, The Journal of infectious diseases.

[27]  D. Watts Antiviral agents. , 1992, Obstetrics and gynecology clinics of North America.

[28]  V. Beral Epidemiology of Kaposi's sarcoma. , 1991, Cancer surveys.

[29]  John E. Bennett,et al.  Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .

[30]  B. Giovanella,et al.  An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection. , 1975, Intervirology.